Jubilant Life Sciences receives ANDA approvals for Irbesartan and Cetirizine
It has received nine ANDA approvals during FY 2015
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Mylan signs exclusive agreement with Gilead Sciences
Under the agreement Mylan will distribute Sovaldi and Harvoni in India
Budget 2015: Awaiting Achche Din
Industry experts share their expectations and wish-list from Budget 2015. FM Arun Jaitley's first Union Budget for heralding the…
Will a new US-led IP empire in India put access to medicines at risk?
Prof Brook K Baker, Professor of Law and Northeastern University, cautions that the Modi government’s accelerating flirtation with…
Glenmark gets US approval for Ashlyna extended-cycle oral contraceptive tablets
The company plans to commence shipping of Ashlyna immediately
Metropolis Healthcare announces price slash for Swine Flu testing
It is one of the few select labs authorised for Swine Flu testing
A Wait and Watch Approach
All sectors, including the pharmaceutical and supply chain industry, are eagerly waiting the implementation of the Goods and…
GST and its impact on pharma
Dr Milind Antani, Legal & Tax Counseling Worldwide, Nishith Desai Associates and Ashish Sodhani, Member, International Tax…
GST: The road ahead
Pratik Jain, Partner — Tax, KPMG India shares insights on the way forward after GST implementation
US FDA raises concerns over Lupin’s plant at Pithampur
FDA inspected the plant in January this year and listed six observations on the manufacturing processes at the plant